$106 Million is the total value of Birchview Capital, LP's 0 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 25.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Buy | CELGENE CORP (CELG) | $44,800,000 | -25.3% | 699,011 | +4.3% | 42.38% | +9.5% |
| AXDX | ACCELERATE DIAGNOSTICS INC | $25,114,000 | -49.9% | 2,183,795 | 0.0% | 23.76% | -26.6% | |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $3,928,000 | -33.4% | 55,000 | +14.6% | 3.72% | -2.4% |
| CMTA | Buy | CLEMENTIA PHARMACEUTICALS INC | $2,611,000 | +92.0% | 222,000 | +82.0% | 2.47% | +181.3% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $2,394,000 | +23.0% | 168,000 | +31.2% | 2.26% | +80.3% |
| QDEL | Buy | QUIDEL CORP | $2,298,000 | +3.8% | 47,075 | +38.6% | 2.17% | +52.1% |
| EQM | New | EQM MIDSTRM PRTNERS LP LTDunit ltd partn | $2,163,000 | – | 50,000 | +100.0% | 2.05% | – |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $2,090,000 | +3.5% | 80,000 | -9.1% | 1.98% | +51.6% |
| ATRA | ATARA BIOTHERAPEUTICS INC | $1,181,000 | -16.0% | 34,000 | 0.0% | 1.12% | +23.0% | |
| SLNO | SOLENO THERAPEUTICS INC | $1,123,000 | -20.8% | 656,598 | 0.0% | 1.06% | +16.1% | |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $1,026,000 | -37.0% | 80,303 | -19.9% | 0.97% | -7.6% |
| IMMY | IMPRIMIS PHARMACEUTICALS INC | $1,024,000 | +104.8% | 180,000 | 0.0% | 0.97% | +200.0% | |
| ALBO | ALBIREO PHARMA INC | $932,000 | -25.6% | 38,000 | 0.0% | 0.88% | +9.2% | |
| MASI | MASIMO CORP | $859,000 | -13.8% | 8,000 | 0.0% | 0.81% | +26.4% | |
| ARNA | ARENA PHARMACEUTICALS INC | $857,000 | -15.3% | 22,000 | 0.0% | 0.81% | +24.2% | |
| T107PS | WRIGHT MEDICAL GROUP NV | $817,000 | -6.2% | 30,000 | 0.0% | 0.77% | +37.5% | |
| XLRN | Buy | ACCELERON PHARMA INC | $813,000 | +18.3% | 18,672 | +55.6% | 0.77% | +73.6% |
| BIIB | Buy | BIOGEN INC | $752,000 | +6.4% | 2,500 | +25.0% | 0.71% | +55.9% |
| CORT | CORCEPT THERAPEUTICS INC | $668,000 | -4.7% | 50,000 | 0.0% | 0.63% | +39.8% | |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $656,000 | -23.0% | 70,000 | +40.0% | 0.62% | +12.9% |
| VRML | Sell | VERMILLION INC | $634,000 | -60.0% | 2,113,933 | -5.3% | 0.60% | -41.3% |
| VCYT | VERACYTE INC | $613,000 | +31.5% | 48,767 | 0.0% | 0.58% | +92.7% | |
| IFRX | INFLARX NV | $582,000 | +6.0% | 16,000 | 0.0% | 0.55% | +55.6% | |
| AMRN | AMARIN CORP PLCspons adr new | $544,000 | -16.4% | 40,000 | 0.0% | 0.52% | +22.6% | |
| SIEN | Sell | SIENTRA INC | $508,000 | -60.1% | 40,000 | -25.0% | 0.48% | -41.5% |
| PXD | Buy | PIONEER NATURAL RESOURCES CO | $500,000 | -4.4% | 3,800 | +26.7% | 0.47% | +39.9% |
| DRNA | DICERNA PHARMACEUTICALS INC | $481,000 | -30.0% | 45,000 | 0.0% | 0.46% | +2.7% | |
| XNCR | XENCOR INC | $445,000 | -7.1% | 12,300 | 0.0% | 0.42% | +36.2% | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | $433,000 | -20.3% | 4,300 | 0.0% | 0.41% | +17.1% | |
| ARVN | ARVINAS INC | $386,000 | -23.7% | 30,000 | 0.0% | 0.36% | +11.6% | |
| CFRX | Sell | CONTRAFECT CORP | $368,000 | -77.7% | 240,203 | -69.9% | 0.35% | -67.3% |
| FOLD | AMICUS THERAPEUTICS INC | $364,000 | -20.7% | 38,000 | 0.0% | 0.34% | +16.2% | |
| CLR | New | CONTINENTAL RESOURCES INC | $322,000 | – | 8,000 | +100.0% | 0.30% | – |
| ECA | Sell | ENCANA CORP | $320,000 | -81.0% | 55,300 | -56.9% | 0.30% | -72.1% |
| NKTR | NEKTAR THERAPEUTICS | $312,000 | -46.1% | 9,500 | 0.0% | 0.30% | -21.1% | |
| VYGR | VOYAGER THERAPEUTICS INC | $310,000 | -50.3% | 33,000 | 0.0% | 0.29% | -27.3% | |
| DOVA | Buy | DOVA PHARMACEUTICALS INC | $303,000 | -51.8% | 40,000 | +33.3% | 0.29% | -29.3% |
| MYGN | MYRIAD GENETICS INC | $291,000 | -36.7% | 10,000 | 0.0% | 0.28% | -7.4% | |
| GTHX | G1 THERAPEUTICS INC | $287,000 | -63.4% | 15,000 | 0.0% | 0.27% | -46.4% | |
| ODT | ODONATE THERAPEUTICS INC | $282,000 | -27.3% | 20,000 | 0.0% | 0.27% | +6.8% | |
| EQT | Sell | EQT CORPORATION | $213,000 | -84.6% | 11,300 | -63.9% | 0.20% | -77.5% |
| AMAG | New | AMAG PHARMACEUTICALS INC | $152,000 | – | 10,000 | +100.0% | 0.14% | – |
| LTHM | New | LIVENT CORP | $138,000 | – | 10,000 | +100.0% | 0.13% | – |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $133,000 | – | 20,000 | +100.0% | 0.13% | – |
| OMED | Buy | ONCOMED PHARMACEUTICALS INC | $129,000 | -48.8% | 172,557 | +45.4% | 0.12% | -25.2% |
| SITOQ | SITO MOBILE LTD | $126,000 | -49.4% | 140,000 | 0.0% | 0.12% | -26.1% | |
| IMGN | New | IMMUNOGEN INC | $106,000 | – | 22,000 | +100.0% | 0.10% | – |
| YTEN | Sell | YIELD10 BIOSCIENCE INC | $97,000 | -75.1% | 122,146 | -54.9% | 0.09% | -63.5% |
| GNMX | AEVI GENOMIC MEDICINE INC | $90,000 | -42.7% | 128,000 | 0.0% | 0.08% | -15.8% | |
| CYTK | CYTOKINETICS INC | $63,000 | -36.4% | 10,000 | 0.0% | 0.06% | -6.2% | |
| TGTX | TG THERAPEUTICS INC | $62,000 | -26.2% | 15,000 | 0.0% | 0.06% | +9.3% | |
| WKHS | WORKHORSE GROUP INC | $13,000 | -51.9% | 25,000 | 0.0% | 0.01% | -29.4% | |
| BIOL | Exit | BIOLASE INC | $0 | – | -40,180 | -100.0% | -0.05% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -189,000 | -100.0% | -0.10% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -14,000 | -100.0% | -0.16% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -6,000 | -100.0% | -0.18% | – |
| TSRO | Exit | TESARO INC | $0 | – | -8,200 | -100.0% | -0.21% | – |
| OPK | Exit | OPKO HEALTH INC | $0 | – | -103,956 | -100.0% | -0.23% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -10,000 | -100.0% | -0.24% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -120,000 | -100.0% | -0.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.